Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Cyp2j11em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Cyp2j11em1flox/Cya

Common Name
Cyp2j11-flox
Product ID
S-CKO-00062
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-100066-Cyp2j11-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Cyp2j11-flox Mouse (Catalog S-CKO-00062) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Cyp2j11-flox
Strain ID
CKOCMP-100066-Cyp2j11-B6J-VA
Gene Name
Cyp2j11
Product ID
S-CKO-00062
Gene Alias
Cyp2j11-ps
Background
C57BL/6JCya
Gene Full Name
cytochrome P450, family 2, subfamily j, polypeptide 11
Modification
Conditional knockout
NCBI ID
100066 (Mouse)
Phenotype
MGI:2140224
Chromosome
Chr 4 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000015368
NCBI Transcript ID
NM_001004141
Target Region
Exon 2
Size of Effective Region
~0.7 kb
Overview of Gene Research
Cyp2j11 is a gene belonging to the cytochrome P450 CYP2J subfamily. Members of this subfamily are involved in the metabolism of fatty acids, generating bioactive compounds. They participate in processes such as the metabolism of arachidonic acid (AA), linoleic acid (LA), and other lipids and xenobiotics [1,4].

Quantitative polymerase chain reaction (qPCR) analysis showed that Cyp2j11 was highly expressed in both male and female mouse kidneys [1]. Tissue distribution studies also found that Cyp2j11 transcripts were most abundant in the kidney and heart, with protein detected primarily in the kidney (proximal convoluted tubules), liver, and heart (cardiomyocytes) [4]. In addition, sex differences in Cyp2j11 mRNA levels were observed in both wild-type and GHR deficient mice, and the constant GH infusion induced heart Cyp2j11 in male C57/B6 mice [2]. HL-1 cells expressed Cyp2j11 to the same extent as mouse hearts, and these cells can metabolize AA to various products, suggesting a role in cardiovascular-related AA metabolism [3]. Also, in a study on selenium against liver injury induced by beta-cypermethrin in mice, Cyp2j11 was significantly enriched in functional categories related to retinol metabolism, linoleic acid metabolism, and Jak-STAT signaling pathway [5].

In conclusion, Cyp2j11 is significantly expressed in multiple tissues like the kidney, heart, and liver, and is involved in fatty acid metabolism, especially AA and LA metabolism. Its expression shows sex-related differences and is associated with some liver injury-related pathways. The study of Cyp2j11 in mouse models helps to understand its role in these biological processes and related disease conditions.

References:
1. Graves, Joan P, Gruzdev, Artiom, Bradbury, J Alyce, Edin, Matthew L, Zeldin, Darryl C. 2015. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation. In Drug metabolism and disposition: the biological fate of chemicals, 43, 1169-80. doi:10.1124/dmd.115.064139. https://pubmed.ncbi.nlm.nih.gov/25994032/
2. Zhang, Furong, Yu, Xuming, He, Chunyan, Wan, Yu, Yue, Jiang. 2015. Effects of sexually dimorphic growth hormone secretory patterns on arachidonic acid metabolizing enzymes in rodent heart. In Toxicology and applied pharmacology, 289, 495-506. doi:10.1016/j.taap.2015.10.011. https://pubmed.ncbi.nlm.nih.gov/26493931/
3. Elshenawy, Osama H, Anwar-Mohamed, Anwar, Abdelhamid, Ghada, El-Kadi, Ayman O S. 2012. Murine atrial HL-1 cell line is a reliable model to study drug metabolizing enzymes in the heart. In Vascular pharmacology, 58, 326-33. doi:10.1016/j.vph.2012.12.002. https://pubmed.ncbi.nlm.nih.gov/23268359/
4. Graves, Joan P, Edin, Matthew L, Bradbury, J Alyce, Tomer, Kenneth B, Zeldin, Darryl C. 2013. Characterization of four new mouse cytochrome P450 enzymes of the CYP2J subfamily. In Drug metabolism and disposition: the biological fate of chemicals, 41, 763-73. doi:10.1124/dmd.112.049429. https://pubmed.ncbi.nlm.nih.gov/23315644/
5. He, Kan, Tang, Qingyang, Gong, Mengting, Liu, Dahai, Huang, Bei. 2019. A transcriptomic study of selenium against liver injury induced by beta-cypermethrin in mice by RNA-seq. In Functional & integrative genomics, 20, 343-353. doi:10.1007/s10142-019-00719-7. https://pubmed.ncbi.nlm.nih.gov/31659573/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research